vs
Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and Perion Network Ltd. (PERI). Click either name above to swap in a different company.
Perion Network Ltd. is the larger business by last-quarter revenue ($368.7M vs $284.0M, roughly 1.3× ACADIA PHARMACEUTICALS INC). ACADIA PHARMACEUTICALS INC runs the higher net margin — 96.3% vs 2.1%, a 94.2% gap on every dollar of revenue. Over the past eight quarters, ACADIA PHARMACEUTICALS INC's revenue compounded faster (17.5% CAGR vs 16.4%).
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
Perion Network Ltd. is a publicly traded advertising technology company that provides digital advertising technology solutions to advertisers, agencies, retailers, and publishers. Its core offerings are delivered through Perion One, a unified omnichannel advertising platform designed to support campaign planning, activation, optimisation, and measurement across channels and verticals including connected television (CTV), digital out-of-home (DOOH), display, video advertising, as well as retai...
ACAD vs PERI — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $284.0M | $368.7M |
| Net Profit | $273.6M | $7.7M |
| Gross Margin | 90.8% | — |
| Operating Margin | 6.1% | 2.0% |
| Net Margin | 96.3% | 2.1% |
| Revenue YoY | 9.4% | — |
| Net Profit YoY | 90.3% | — |
| EPS (diluted) | $1.61 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $284.0M | — | ||
| Q3 25 | $278.6M | $368.7M | ||
| Q2 25 | $264.6M | $266.5M | ||
| Q1 25 | $244.3M | $157.8M | ||
| Q4 24 | $259.6M | — | ||
| Q3 24 | $250.4M | $508.9M | ||
| Q2 24 | $242.0M | $323.6M | ||
| Q1 24 | $205.8M | $145.2M |
| Q4 25 | $273.6M | — | ||
| Q3 25 | $71.8M | $7.7M | ||
| Q2 25 | $26.7M | $5.6M | ||
| Q1 25 | $19.0M | $11.8M | ||
| Q4 24 | $143.7M | — | ||
| Q3 24 | $32.8M | $78.0M | ||
| Q2 24 | $33.4M | $45.2M | ||
| Q1 24 | $16.6M | $23.8M |
| Q4 25 | 90.8% | — | ||
| Q3 25 | 92.2% | — | ||
| Q2 25 | 92.2% | — | ||
| Q1 25 | 91.7% | — | ||
| Q4 24 | 91.6% | — | ||
| Q3 24 | 92.5% | — | ||
| Q2 24 | 92.5% | — | ||
| Q1 24 | 88.8% | — |
| Q4 25 | 6.1% | — | ||
| Q3 25 | 12.8% | 2.0% | ||
| Q2 25 | 12.2% | -1.7% | ||
| Q1 25 | 7.9% | 5.4% | ||
| Q4 24 | 59.1% | — | ||
| Q3 24 | 12.6% | 15.1% | ||
| Q2 24 | 12.6% | 13.7% | ||
| Q1 24 | 7.4% | 16.9% |
| Q4 25 | 96.3% | — | ||
| Q3 25 | 25.8% | 2.1% | ||
| Q2 25 | 10.1% | 2.1% | ||
| Q1 25 | 7.8% | 7.5% | ||
| Q4 24 | 55.4% | — | ||
| Q3 24 | 13.1% | 15.3% | ||
| Q2 24 | 13.8% | 14.0% | ||
| Q1 24 | 8.0% | 16.4% |
| Q4 25 | $1.61 | — | ||
| Q3 25 | $0.42 | — | ||
| Q2 25 | $0.16 | — | ||
| Q1 25 | $0.11 | — | ||
| Q4 24 | $0.86 | — | ||
| Q3 24 | $0.20 | — | ||
| Q2 24 | $0.20 | — | ||
| Q1 24 | $0.10 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $177.7M | $156.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.2B | $722.9M |
| Total Assets | $1.6B | $915.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $177.7M | — | ||
| Q3 25 | $258.0M | $156.2M | ||
| Q2 25 | $253.6M | $156.2M | ||
| Q1 25 | $217.7M | $156.2M | ||
| Q4 24 | $319.6M | — | ||
| Q3 24 | $155.1M | $187.6M | ||
| Q2 24 | $177.1M | $187.6M | ||
| Q1 24 | $204.7M | $187.6M |
| Q4 25 | $1.2B | — | ||
| Q3 25 | $917.3M | $722.9M | ||
| Q2 25 | $822.4M | $722.9M | ||
| Q1 25 | $765.2M | $722.9M | ||
| Q4 24 | $732.8M | — | ||
| Q3 24 | $577.2M | $718.1M | ||
| Q2 24 | $516.7M | $718.1M | ||
| Q1 24 | $464.0M | $718.1M |
| Q4 25 | $1.6B | — | ||
| Q3 25 | $1.3B | $915.5M | ||
| Q2 25 | $1.2B | $915.5M | ||
| Q1 25 | $1.1B | $915.5M | ||
| Q4 24 | $1.2B | — | ||
| Q3 24 | $976.9M | $1.1B | ||
| Q2 24 | $914.1M | $1.1B | ||
| Q1 24 | $855.1M | $1.1B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.7M | $2.6M |
| Free Cash FlowOCF − Capex | — | $-2.9M |
| FCF MarginFCF / Revenue | — | -0.8% |
| Capex IntensityCapex / Revenue | — | 1.5% |
| Cash ConversionOCF / Net Profit | -0.18× | 0.34× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-48.7M | — | ||
| Q3 25 | $74.3M | $2.6M | ||
| Q2 25 | $64.0M | — | ||
| Q1 25 | $20.3M | — | ||
| Q4 24 | $40.4M | — | ||
| Q3 24 | $63.2M | $105.2M | ||
| Q2 24 | $25.0M | — | ||
| Q1 24 | $29.1M | $17.8M |
| Q4 25 | — | — | ||
| Q3 25 | $73.9M | $-2.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $63.2M | $104.7M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $17.6M |
| Q4 25 | — | — | ||
| Q3 25 | 26.5% | -0.8% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 25.2% | 20.6% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 12.2% |
| Q4 25 | — | — | ||
| Q3 25 | 0.1% | 1.5% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.0% | 0.1% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.1% |
| Q4 25 | -0.18× | — | ||
| Q3 25 | 1.03× | 0.34× | ||
| Q2 25 | 2.40× | — | ||
| Q1 25 | 1.07× | — | ||
| Q4 24 | 0.28× | — | ||
| Q3 24 | 1.93× | 1.35× | ||
| Q2 24 | 0.75× | — | ||
| Q1 24 | 1.76× | 0.75× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACAD
| Nuplazid | $174.4M | 61% |
| Daybue | $109.6M | 39% |
PERI
| Advertising Solutions | $231.4M | 63% |
| Search Advertising | $137.3M | 37% |
